A recent study reveals that federal initiatives aimed at reducing antipsychotic (AP) use in nursing home residents with dementia have had limited impact on the duration of treatment. Analyzing data from 43,668 new AP initiations among 38,275 long-stay residents, researchers found that the average duration of treatment within six months only marginally decreased from 125.9 days prior to the National Partnership to Improve Dementia Care (2012) to 120.5 days and 120.6 days after the policy changes.

The findings underscore a critical gap in the effectiveness of these policies, as over half of the residents continued AP treatment beyond six months, despite the intended reductions. This suggests that while federal measures have influenced discontinuation rates—showing a higher likelihood of stopping treatment post-policy changes—the overall duration of AP use remains concerningly high.

For longevity and healthspan professionals, this study highlights the need for more effective strategies to manage AP prescriptions in dementia care, emphasizing the importance of ongoing evaluation and adaptation of policy frameworks to improve patient outcomes.

Source: academic.oup.com